Literature DB >> 8137927

Amiodarone-induced hypercholesterolemia is associated with a decrease in liver LDL receptor mRNA.

F Hudig1, O Bakker, W M Wiersinga.   

Abstract

Amiodarone decreases plasma and tissue triiodothyronine (T3) and increases plasma cholesterol levels resembling changes seen during hypothyroidism. To elucidate the mechanism of amiodarone-induced hypercholesterolemia we investigated gene expression of three key proteins in cholesterol metabolism (cholesterol 7 alpha-hydroxylase, LDL receptor, HMG-CoA reductase) in livers of rats. Animals were treated with amiodarone or propylthiouracil (to induce mild hypothyroidism). The LDL receptor mRNA was downregulated (approximately 50%) in both amiodarone-treated and hypothyroid animals, while the other mRNA remained unchanged after 14-day treatment. The results suggest that amiodarone-induced hypercholesterolemia is associated with decreased LDL receptor mRNA levels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8137927     DOI: 10.1016/0014-5793(94)80245-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  2 in total

1.  Inhibition of the type 2 iodothyronine deiodinase underlies the elevated plasma TSH associated with amiodarone treatment.

Authors:  Matthew L Rosene; Gábor Wittmann; Rafael Arrojo e Drigo; Praful S Singru; Ronald M Lechan; Antonio C Bianco
Journal:  Endocrinology       Date:  2010-10-06       Impact factor: 4.736

2.  Statin resistant dyslipidemia in a patient treated with amiodarone.

Authors:  Ahmad Al-Sarraf; Min Li; Jiri Frohlich
Journal:  BMJ Case Rep       Date:  2011-10-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.